<p><b>Abbreviations</b>: * median; PFS, progression-free-survival; OS, overall survival; RR, response rate for 1th line therapy (complete, partial, stable); 95% CI, confidential interval 95%.</p>A<p>Log rank test;</p>B<p>Breslow test;</p>C<p>Chi square test;</p>D<p>Breslow test (only non-squamous cell tumors);</p>E<p>Log rank test (only stages IIIB and IV);</p>F<p>Log rank test (only non-squamous cell tumors);</p>G<p>Breslow test (only stages IIIB and IV). <b>Bold</b> was used for highlight almost statistical significance results and <b>bold+gray</b> for statistic significant results.; <sup>†</sup>adjusted for age<b>.</b></p
In lung cancer, the survival of patients with the same clinical stage varies widely for unknown reas...
Purpose: The main prognostic factor of lung cancer patient outcome is clinical stage, a parameter of...
<div><p>Background</p><p>This study was conducted to investigate whether a panel of eight genetic po...
Lung cancer is one of the most common cancers in the western world, and closely related to smoking. ...
Introduction:Lung cancer is the leading global cause of cancer-related mortality. Interindividual va...
Background: Lung cancer is one of the most frequent malignancy with high mortality rate. Non small c...
SNPs and clinical outcome of platinum-based chemotherapy in non-small cell lung cancer (NSCLC) pati...
Background: Single nucleotide polymorphisms (SNPs) in the DNA repair genes are suspected to be relat...
Lung cancer is a highly prevalent disease worldwide. Currently, it is the leading cause of cancer-re...
In lung cancer, the survival of patients with the same clinical stage varies widely for unknown reas...
<p><b>Abbreviations:</b> NSCLC, non-small-cell lung cancer; vWF, von Willebrand factor; CHRNA3, chol...
<p>Abbreviations: NSCLC, non-small cell lung cancer; HR, hazard ratio; CI, confidence interval.</p
polymorphisms affect clinical efficacy among advanced non-small cell lung cancer (NSCLC) patients t...
This study was conducted to investigate whether a panel of eight genetic polymorphisms can predict t...
<div><p>Objectives</p><p>We aimed to determine the associations of genetic polymorphisms of excision...
In lung cancer, the survival of patients with the same clinical stage varies widely for unknown reas...
Purpose: The main prognostic factor of lung cancer patient outcome is clinical stage, a parameter of...
<div><p>Background</p><p>This study was conducted to investigate whether a panel of eight genetic po...
Lung cancer is one of the most common cancers in the western world, and closely related to smoking. ...
Introduction:Lung cancer is the leading global cause of cancer-related mortality. Interindividual va...
Background: Lung cancer is one of the most frequent malignancy with high mortality rate. Non small c...
SNPs and clinical outcome of platinum-based chemotherapy in non-small cell lung cancer (NSCLC) pati...
Background: Single nucleotide polymorphisms (SNPs) in the DNA repair genes are suspected to be relat...
Lung cancer is a highly prevalent disease worldwide. Currently, it is the leading cause of cancer-re...
In lung cancer, the survival of patients with the same clinical stage varies widely for unknown reas...
<p><b>Abbreviations:</b> NSCLC, non-small-cell lung cancer; vWF, von Willebrand factor; CHRNA3, chol...
<p>Abbreviations: NSCLC, non-small cell lung cancer; HR, hazard ratio; CI, confidence interval.</p
polymorphisms affect clinical efficacy among advanced non-small cell lung cancer (NSCLC) patients t...
This study was conducted to investigate whether a panel of eight genetic polymorphisms can predict t...
<div><p>Objectives</p><p>We aimed to determine the associations of genetic polymorphisms of excision...
In lung cancer, the survival of patients with the same clinical stage varies widely for unknown reas...
Purpose: The main prognostic factor of lung cancer patient outcome is clinical stage, a parameter of...
<div><p>Background</p><p>This study was conducted to investigate whether a panel of eight genetic po...